Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 3:12:03080.
doi: 10.7189/jogh.12.03080.

COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play

Lyn R Frumkin  1 , Michaela Lucas  2 , Michael Wallach  3   4 , Curtis L Scribner  5 , Tom St John  1 , Daria Mochly-Rosen  1   6   7
Affiliations

COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play

Lyn R Frumkin et al. J Glob Health. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and declare the following activities and relationships: DM-R is named on a patent filed for composition and methods for passive immunization against viral infections such as SARS-CoV-2. MW is a consultant for Camus, Inc, Minnesota. The remaining authors declare no relevant interests.

Figures

Figure 1
Figure 1
Anti-SARS-CoV-2 IgY as passive immunization against COVID-19 (modified from [23] under CC BY 4.0 license).
None
Photo: Extraction and purification of immunoglobulin Y (IgY). Source: Ana Koperniku and Allison Jia, Stanford University. Used with permission.
See this image and copyright information in PMC

References

    1. University of Oxford. Vaccination by location. Available: https://ourworldindata.org/covid-vaccinations?country=OWID_WRL. Accessed October 25, 2022.
    1. Katz IT, Weintraub R, Bekker LG, Brandt AM.From Vaccine Nationalism to Vaccine Equity — Finding a Path Forward. N Engl J Med. 2021;384:1281-3. 10.1056/NEJMp2103614 - DOI - PubMed
    1. Hu B, Guo H, Zhou P, Shi Z-L.Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141-54. 10.1038/s41579-020-00459-7 - DOI - PMC - PubMed
    1. Kim Y-II, Kim D, Yu K-M, Seo HD, Lee S-A, Casel MAB, et al. Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate Against SARS-CoV-2 Infection in Ferrets. MBio. 2021;12:e00230-21. 10.1128/mBio.00230-21 - DOI - PMC - PubMed
    1. Palit P, Chattopadhyay D, Thomas SS, Kundu A, Kim HS, Rezaeif N.Phytopharmaceuticals Mediated Furin and TMPRSS2 Receptor Blocking: Can it be a Potential Therapeutic Option for Covid-19? Phytomedicine. 2021;85:153396. 10.1016/j.phymed.2020.153396 - DOI - PMC - PubMed